|
Pulse Biosciences, Inc. (PLSE) Évaluation DCF
US | Healthcare | Medical - Instruments & Supplies | NASDAQ
|
- ✓ Entièrement Modifiable: Adapté À Vos Besoins Dans Excel Ou Sheets
- ✓ Conception Professionnelle: Modèles Fiables Et Conformes Aux Normes Du Secteur
- ✓ Pré-Construits Pour Une Utilisation Rapide Et Efficace
- ✓ Aucune Expertise N'Est Requise; Facile À Suivre
Pulse Biosciences, Inc. (PLSE) Bundle
Vous cherchez à déterminer la valeur intrinsèque de Pulse Biosciences, Inc.? Notre calculatrice (PLSE) DCF intègre des données réelles ainsi que des fonctionnalités de personnalisation étendues, vous permettant d'ajuster les prévisions et d'améliorer vos choix d'investissement.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | .0 | .0 | 1.4 | .7 | .0 | .0 | .0 | .0 | .0 | .0 |
| Revenue Growth, % | 0 | 0 | 0 | -50.63 | -100 | -37.66 | -37.66 | -37.66 | -37.66 | -37.66 |
| EBITDA | -46.8 | -48.9 | -61.9 | -56.7 | -42.4 | .0 | .0 | .0 | .0 | .0 |
| EBITDA, % | 100 | 100 | -4363.05 | -8100.29 | 100 | 20 | 20 | 20 | 20 | 20 |
| Depreciation | 1.2 | 1.1 | 1.1 | 1.4 | 1.2 | .0 | .0 | .0 | .0 | .0 |
| Depreciation, % | 100 | 100 | 80.82 | 193.57 | 100 | 96.16 | 96.16 | 96.16 | 96.16 | 96.16 |
| EBIT | -48.0 | -50.0 | -63.0 | -58.1 | -43.6 | .0 | .0 | .0 | .0 | .0 |
| EBIT, % | 100 | 100 | -4443.86 | -8293.86 | 100 | 20 | 20 | 20 | 20 | 20 |
| Total Cash | 25.4 | 20.5 | 28.6 | 61.1 | 44.4 | .0 | .0 | .0 | .0 | .0 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | .0 | .0 | .1 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables, % | 100 | 100 | 4.3 | 0 | 100 | 60.86 | 60.86 | 60.86 | 60.86 | 60.86 |
| Inventories | .0 | .0 | 5.8 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Inventories, % | 100 | 100 | 410.72 | 0 | 100 | 80 | 80 | 80 | 80 | 80 |
| Accounts Payable | 2.0 | 1.7 | 2.9 | 1.6 | 1.8 | .0 | .0 | .0 | .0 | .0 |
| Accounts Payable, % | 100 | 100 | 204.8 | 224.71 | 100 | 100 | 100 | 100 | 100 | 100 |
| Capital Expenditure | -.6 | -.4 | -.4 | -.4 | -.1 | .0 | .0 | .0 | .0 | .0 |
| Capital Expenditure, % | 100 | 100 | -30.82 | -57.29 | 100 | -17.62 | -17.62 | -17.62 | -17.62 | -17.62 |
| Tax Rate, % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBITAT | -47.0 | -49.9 | -62.5 | -58.5 | -43.6 | .0 | .0 | .0 | .0 | .0 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -44.4 | -49.4 | -66.5 | -53.0 | -42.2 | -1.8 | .0 | .0 | .0 | .0 |
| WACC, % | 12.8 | 12.8 | 12.8 | 12.8 | 12.8 | 12.8 | 12.8 | 12.8 | 12.8 | 12.8 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -1.6 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | 0 | |||||||||
| Terminal Value | 0 | |||||||||
| Present Terminal Value | 0 | |||||||||
| Enterprise Value | -2 | |||||||||
| Net Debt | -35 | |||||||||
| Equity Value | 34 | |||||||||
| Diluted Shares Outstanding, MM | 48 | |||||||||
| Equity Value Per Share | 0.70 |
What You Will Receive
- Customizable Excel Template: A fully adjustable Excel-based DCF Calculator featuring pre-loaded real PLSE financials.
- Accurate Data: Historical figures and forward-looking projections (displayed in the highlighted cells).
- Adjustable Forecasts: Modify forecast parameters such as revenue growth, EBITDA %, and WACC.
- Instant Calculations: Quickly observe how your inputs affect Pulse Biosciences' valuation.
- Professional Resource: Designed for investors, CFOs, consultants, and financial analysts.
- User-Friendly Interface: Organized for clarity and simplicity, complete with step-by-step guidance.
Key Features
- 🔍 Real-Life PLSE Financials: Pre-filled historical and projected data for Pulse Biosciences, Inc.
- ✏️ Fully Customizable Inputs: Adjust all critical parameters (yellow cells) like WACC, growth %, and tax rates.
- 📊 Professional DCF Valuation: Built-in formulas calculate Pulse Biosciences’ intrinsic value using the Discounted Cash Flow method.
- ⚡ Instant Results: Visualize Pulse Biosciences’ valuation instantly after making changes.
- Scenario Analysis: Test and compare outcomes for various financial assumptions side-by-side.
How It Works
- Step 1: Download the Excel file.
- Step 2: Review pre-entered Pulse Biosciences data (historical and projected).
- Step 3: Adjust key assumptions (yellow cells) based on your analysis.
- Step 4: View automatic recalculations for Pulse Biosciences’ intrinsic value.
- Step 5: Use the outputs for investment decisions or reporting.
Why Choose This Calculator for Pulse Biosciences, Inc. (PLSE)?
- User-Friendly Interface: Tailored for both novice users and seasoned professionals.
- Customizable Inputs: Easily adjust parameters to suit your financial analysis.
- Real-Time Feedback: Observe immediate updates to Pulse Biosciences’ valuation as you modify inputs.
- Preloaded Data: Comes equipped with Pulse Biosciences’ actual financial metrics for swift evaluation.
- Relied Upon by Experts: Widely utilized by investors and analysts for data-driven decision making.
Who Should Use This Product?
- Investors: Accurately estimate Pulse Biosciences, Inc.'s (PLSE) fair value before making investment decisions.
- CFOs: Leverage a professional-grade DCF model for financial reporting and analysis of Pulse Biosciences, Inc. (PLSE).
- Consultants: Quickly adapt the template for valuation reports for clients focusing on Pulse Biosciences, Inc. (PLSE).
- Entrepreneurs: Gain insights into financial modeling used by leading biotech firms like Pulse Biosciences, Inc. (PLSE).
- Educators: Use it as a teaching tool to demonstrate valuation methodologies relevant to Pulse Biosciences, Inc. (PLSE).
What the Template Contains
- Operating and Balance Sheet Data: Pre-filled Pulse Biosciences historical data and forecasts, including revenue, EBITDA, EBIT, and capital expenditures.
- WACC Calculation: A dedicated sheet for Weighted Average Cost of Capital (WACC), including parameters like Beta, risk-free rate, and share price.
- DCF Valuation (Unlevered and Levered): Editable Discounted Cash Flow models showing intrinsic value with detailed calculations.
- Financial Statements: Pre-loaded financial statements (annual and quarterly) to support analysis.
- Key Ratios: Includes profitability, leverage, and efficiency ratios for Pulse Biosciences, Inc. (PLSE).
- Dashboard and Charts: Visual summary of valuation outputs and assumptions to analyze results easily.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.